MartÃnez-Bosch, N.; Vilariño, N.; Alameda, F.; Mojal, S.; ArumÃ-Uria, M.; Carrato, C.; Aldecoa, I.; Ribalta, T.; Vidal, N.; Bellosillo, B.;
et al. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells 2023, 12, 843.
https://doi.org/10.3390/cells12060843
AMA Style
MartÃnez-Bosch N, Vilariño N, Alameda F, Mojal S, ArumÃ-Uria M, Carrato C, Aldecoa I, Ribalta T, Vidal N, Bellosillo B,
et al. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells. 2023; 12(6):843.
https://doi.org/10.3390/cells12060843
Chicago/Turabian Style
MartÃnez-Bosch, Neus, Noelia Vilariño, Francesc Alameda, Sergi Mojal, Montserrat ArumÃ-Uria, Cristina Carrato, Iban Aldecoa, Teresa Ribalta, Noemà Vidal, Beatriz Bellosillo,
and et al. 2023. "Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker" Cells 12, no. 6: 843.
https://doi.org/10.3390/cells12060843
APA Style
MartÃnez-Bosch, N., Vilariño, N., Alameda, F., Mojal, S., ArumÃ-Uria, M., Carrato, C., Aldecoa, I., Ribalta, T., Vidal, N., Bellosillo, B., Menéndez, S., Del Barco, S., Gallego, O., Pineda, E., López-Martos, R., Hernández, A., Mesia, C., Esteve-Codina, A., de la Iglesia, N.,
... Navarro, P.
(2023). Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells, 12(6), 843.
https://doi.org/10.3390/cells12060843
